We previously shed some lights into a role of vitamin D, which exerts a protective effect on vessels against NH formation, emphasizing that histological NH lesions consist of vitamin D receptor (VDR)-positive myofibroblasts. 6 Virtual histology (VH), derived from intravascular ultrasound (IVUS) images, provides novel insights into atherosclerotic coronary arterial disease, allowing detailed scrutiny of plaque composition and classification of coronary lesions. 7 Although vitamin D and its receptor activators have been vigorously studied in terms of efficacy in vascular smooth muscle cells (VSMCs), there is still a missing link between VDR-rich NH stenotic lesions and VH findings from IVUS images.
This study was conducted to elucidate possible correlation between IVUS-VH presenting tissue images and real pathological stenotic lesions, characterized by NH-rich vessel hypertrophy.
Patients and methods

Patients
We examined 10 patients with recurrent VA stenosis who underwent repeatedly ultrasound-guided balloon catheter interventions without using intravenous radiocontrast administration, because they all had severe radiocontrast allergy or anaphylactic shock. Their culprit vessel stenotic lesions were in the axillary vein, the subclavian vein or the brachiocephalic vein.
IVUS system and its image construction
The Eagle Eye Platinum Digital IVUS catheter (Philips, Tokyo, Japan), featuring its enhanced lubricity, pushability, and compatibility to target vessel lumens, was applied to evaluate vessel stenotic lesions before and after balloon catheter intervention.
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into several tissue types with 93%-97% accuracy. 8 Theoretically, VH technology assesses and codes tissue composition as green (fibrous), white (dense calcium), and red (necrotic core).
VA intervention strategy: balloon expansion angioplasty and VA surgical procedure
All patients underwent IVUS-guided percutaneous transluminal angioplasty (PTA). Conventional balloon dilatation catheters (Ultra-thin diamond or Mustang, Boston Scientific Japan, Tokyo, Japan) were used to enlarge stenotic vessels up to their rated balloon pressures if applicable.
VA surgery was performed when significant underlying vessel restenosis was refractory to recanalization even by repeatedly intensive conventional PTAs. The tissue specimens of exactly stenotic vessels were obtained from vascular surgeries in 3 out of 10 patients who had undergone repeated IVUS-VH analyses to reconstruct virtually histological composition of stenotic lesions.
The study was approved by the local ethical committee and was also in adherence with the Declaration of Helsinki.
Immunohistochemistry
The tissue specimens of vascular stenotic anastomosis were fixed in 10% buffered formalin and embedded in paraffin for routine processing. Serial sections of 3-5 µm thickness were obtained from the paraffin embedded block. We stained them for hematoxylin and eosin (HE) and Elastica van Gieson (EVG). For immunohistochemistry (IHC), adjacent sections were stained for VDR (1:10000 dilution; Abcam, Inc., Cambridge, UK) as described elsewhere 9 and incubated with horseradishconjugated secondary antibody (Nichirei Corporation, Tokyo, Japan). Nuclear VDR immunoreactivity was analyzed and the positive cell number ratio (%) was calculated using ImageJ.
Results
Between 2004 and 2017, 10 hemodialysis patients with severe radiocontrast reaction were identified in our center. Their mean follow-up period was longer than 10 years (Table 1) , and they underwent 4-8 IVUS-guided PTA procedures in each year because of resistant VA restenosis.
IVUS imaging and its VH construction
The IVUS catheter detected marked outflow vessel stenosis (Figure 1(a) ), and its VH construction revealed advanced intimal hypertrophy of fibrous tissue ( Figure  1(b) ). Successful PTA created large-enough luminal space, by cracking hypertrophic vessel wall (Figure 1(c) ).
A distinctive cross section of graft-axillary vein anastomosis (Figure 2, left) indicates abundant green tissue, presumably Values are mean ± SD or n (%).
considered neointimal hyperplastic myofibroblasts, invasively reached the arteriovenous graft anastomosis, resulting in marked outflow stenosis (Figure 2 , right, white arrow).
Pathophysiological analysis, VH-constructed vessel wall tissue composition, and their mutual relevance
Consecutive cross-sectional analyses, obtained from surgically excised stenotic vessels, suggest that hyperplastic vessel wall (Figure 3(a) ) has EVG strongly positive multilayer thickening structure (Figure 3(b) ), indicating established NH formation. VDR-positive cells are the major component of NH (Figure 3(d) and (e)). Hyperplastic vessel wall (Figure 3(b) ) is relevant to abundantly expressed fibrous tissue according to VH-constructed vessel wall imaging (Figure 3(c) ).
NH progression and nuclear VDR positivity
Comprehensive assessment of consecutive cross-sectional VH images (Figure 2) indicates that VH-constructed green tissue progression in vessel walls (Figure 4 , color background) had abundant VDR-positive cells in three patients with resistant VA stenosis, who eventually underwent vascular surgeries (Figure 4 ). Marked stenosis and neointimal hyperplastic green tissue at the venous-graft anastomosis, derived from virtual histological images. Intra-graft (white arrows) hypertrophic vessel wall stenosis is observed by occupying lumen space with green fibrous tissue.
Discussion
Our data from the current small but long-term study support the evidence that outflow vessel NH development is a major cause for VA stenosis. The underline mechanism overwhelmingly includes VDR-positive myofibroblast-abundant intraluminal hypertrophy. 10 In the clinical setting, we could not examine the relation between outflow vessel NH-and VH-constructed fibrous tissue without any pathological findings obtained from VA surgeries. We have first demonstrated that repeated IVUS-guided PTA procedures provide solid results: IVUS-VH technology illustrates and classifies vessel wall thickness, which is perfectly equivalent to pathological NH formation. Interestingly enough, VH-constructed green tissue represents VDR-positive myofibroblasts. Local vessel wall administration of VDR activators may be a promising option to help prevent NH development at VA stenotic sited like other antiproliferative agents. 11 One of our study limitations is that no de novo lesions were not included, which could be more instructive to understand the precise mechanism of NH formation at VA stenosis.
Conclusion
Our 10-year follow-up data of hemodialysis patients with resistant VA stenosis clarify robust correlation between VDR-rich neointimal vessel hypertrophy and IVUSassisted virtual histological analysis.
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